Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the Bank of America Merrill Lynch 2017 Health Care Conference
May 11, 2017 16:05 ET
|
Sucampo Pharmaceuticals Inc
ROCKVILLE, Md., May 11, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will webcast its corporate...
Sucampo Reports First Quarter 2017 Financial Results
May 03, 2017 06:30 ET
|
Sucampo Pharmaceuticals Inc
Continued Revenue Growth Recent Vtesse Acquisition Bolsters Pipeline Company Reiterates 2017 Guidance Company to Host Conference Call Today at 8:30 a.m. EDT ROCKVILLE, Md., May 03, 2017 (GLOBE...
Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the Deutsche Bank 42nd Annual Health Care Conference
April 26, 2017 16:01 ET
|
Sucampo Pharmaceuticals Inc
ROCKVILLE, Md., April 26, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will webcast its corporate...
New Study Published in PLOS ONE Advances Science Around VTS-270 for Treatment of Niemann-Pick Disease Type C1
April 18, 2017 06:30 ET
|
Sucampo Pharmaceuticals Inc
ROCKVILLE, Md., April 18, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today announced the publication of a new study in an...
Sucampo Acquires Vtesse Inc.
April 03, 2017 06:30 ET
|
Sucampo Pharmaceuticals Inc
Transaction Valued at $200 Million Upfront Diversifies Pipeline with Late Stage Program in Niemann-Pick Disease Type C1 (NPC-1) Increases Company Focus on Specialized Diseases with High Unmet Need ...
Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 16th Annual Needham Healthcare Conference
March 28, 2017 16:01 ET
|
Sucampo Pharmaceuticals Inc
ROCKVILLE, Md., March 28, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will webcast its corporate...
Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the Oppenheimer 27th Annual Healthcare Conference
March 15, 2017 17:01 ET
|
Sucampo Pharmaceuticals Inc
ROCKVILLE, Md., March 15, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will webcast its corporate...
Sucampo Reports Fourth Quarter and Full Year 2016 Financial Results
March 08, 2017 06:30 ET
|
Sucampo Pharmaceuticals Inc
Continued Revenue Growth Leads to Strong Income Growth Company Reiterates 2017 Guidance Company Announces Key Executive Transitions Company to Host Conference Call Today at 8:30 a.m. EST ...
Sucampo Announces Fourth Quarter and Full Year 2016 Earnings Call
February 23, 2017 16:02 ET
|
Sucampo Pharmaceuticals Inc
ROCKVILLE, Md., Feb. 23, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today announced that it will host its fourth quarter and...
Sucampo Announces Pricing of $260.0 Million 3.25% Convertible Senior Notes due 2021
December 21, 2016 02:00 ET
|
Sucampo Pharmaceuticals Inc
ROCKVILLE, Md., Dec. 21, 2016 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP), a global biopharmaceutical company, today announced the December 20, 2016 pricing of $260.0 million...